Abeona Therapeutics (ABEO) Short-term Investments (2011 - 2026)

Abeona Therapeutics' Short-term Investments history runs 11 years deep, the most recent figure standing at $106.9 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 56.7% year-over-year to $106.9 million; the TTM figure through Mar 2026 stood at $106.9 million (up 56.7% YoY), while the FY2025 annual figure was $113.0 million, up 51.91% from the prior year.
• Short-term Investments was $106.9 million for Q1 2026 at Abeona Therapeutics, down from $113.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $124.2 million in Q3 2025 to a low of $11.0 million in Q1 2022.
• Historically, Short-term Investments has averaged $59.1 million across 5 years, with a median of $49.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments slumped 84.84% in 2022, then jumped 294.42% in 2023.
• A 5-year view of Short-term Investments shows it stood at $37.9 million in 2022, then retreated by 0.47% to $37.8 million in 2023, then jumped by 96.97% to $74.4 million in 2024, then surged by 51.91% to $113.0 million in 2025, then fell by 5.37% to $106.9 million in 2026.
• The last three Short-term Investments figures came in at $106.9 million (Q1 2026), $113.0 million (Q4 2025), and $124.2 million (Q3 2025), per Business Quant data.